FDA Approves, Leqembi, New Treatment for Early Alzheimer’s
The drug, Leqembi, may modestly slow cognitive decline in early [...]
Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen
The report said the F.D.A.’s approval process for Aduhelm was [...]
The F.D.A. Now Says It Plainly: Morning-After Pills Are Not Abortion Pills
Labels of Plan B One-Step had previously said, without scientific [...]
Senators Question Califf, the F.D.A. Nominee, on Opioid Crisis and Pandemic Response
A Senate panel hearing on Tuesday signaled that Dr. Robert [...]
Specialty Pharmacies Cater to the Blind and Those With Impaired Vision
The pandemic has exposed flaws in services for people who [...]
How an Unproven Alzheimer’s Drug Got Approved
Though some of its own senior officials said there was [...]